W Flamenbaum
Overview
Explore the profile of W Flamenbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
410
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shum L, Pieniaszek Jr H, Robinson C, DAVIDSON A, Widner P, Benedek I, et al.
J Clin Pharmacol
. 1996 Dec;
36(12):1161-8.
PMID: 9013374
Sixteen healthy male volunteers completed a nonrandomized, sequential, three-phase study. The three phases were 1) moricizine at 250 mg every 8 hours for 7 days with 12 days washout; 2)...
2.
Hall W, Weber M, Ferdinand K, Flamenbaum W, Marbury T, Jain A, et al.
J Hum Hypertens
. 1994 Aug;
8(8):571-5.
PMID: 7990083
Indapamide (Lozol), an indoline antihypertensive drug with diuretic and vasodilating activities, was evaluated in 195 patients with mild to moderate essential hypertension (sitting DBP between 95 and 110 mmHg) in...
3.
Weir M, Fagan T, Chrysant S, Flamenbaum W, Kaihlanen P, Lueg M, et al.
J Hum Hypertens
. 1994 Jul;
8(7):531-7.
PMID: 7932518
One hundred and ten patients (mean age 50.6 years) with moderate to severe essential hypertension (DBP between 105 and 116 mmHg) were randomised to eight weeks of double-blind treatment with...
4.
Mathew N, Dexter J, Couch J, Flamenbaum W, Goldstein J, Rapoport A, et al.
Arch Neurol
. 1992 Dec;
49(12):1271-6.
PMID: 1333181
Sumatriptan, a specific serotonin1-like receptor agonist, was studied in the acute treatment of migraine. Two hundred forty-two adult migraineurs participated in a randomized, double-blind study in which one dose of...
5.
Itskovitz H, Flamenbaum W, De Gaetano C, Pritchard Jr K, Stemerman M
Clin Ther
. 1989 Nov;
11(6):862-72.
PMID: 2611825
The effect of lovastatin on serum lipids and its tolerability in patients with non-familial primary hypercholesterolemia (type II-A and type II-B) during a six-month period were evaluated in this open-label...
6.
Flamenbaum W
Am J Cardiol
. 1989 Jun;
63(19):54-57I.
PMID: 2658530
The risk for development of coronary heart disease (CHD) is related to a number of factors. Among these, both hypertension and various lipid abnormalities have been shown to play an...
7.
Frishman W, Flamenbaum W, Schoenberger J, Schwartz G, Vidt D, Neri G, et al.
Am J Cardiol
. 1989 Apr;
63(12):839-42.
PMID: 2522723
The safety and efficacy of orally administered celiprolol, a new beta 1-selective adrenergic blocking drug with peripheral beta 2-agonist properties, were assessed in 91 patients with mild to moderate systemic...
8.
Kaplan N, Alderman M, Flamenbaum W, McCarron D, Perry H, Saunders E, et al.
Am J Hypertens
. 1989 Feb;
2(2 Pt 1):75-7.
PMID: 2644949
No abstract available.
9.
Flamenbaum W
Am J Hypertens
. 1989 Feb;
2(2 Pt 2):86S-89S.
PMID: 2563944
While there is general agreement on the natural history, pathology, and pathophysiology of hypertension, there continues to be controversy over the selection of specific antihypertensive agents. All antihypertensive agents will,...
10.
Swartz R, Flamenbaum W, Dubrow A, Hall J, Crow J, Cato A
J Clin Pharmacol
. 1988 Sep;
28(9):818-25.
PMID: 3068260
The frequency of hemodialysis-associated hemorrhage was studied prospectively in two successive, parallel, heparin-controlled studies using epoprostenol (PGI2; average dose, 4.1 ng/kg.min) as the sole antithrombotic agent. Sixty-three patients with active...